Rea, D., Gray, R., Bowden, S., Handley, K., Earl, H., Poole, C., . . . Lee, M. (2013). Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer.
Παραπομπή σε μορφή Chicago (17η εκδ.)Rea, D., et al. Overall and Subgroup Findings of the ATTom Trial: A Randomised Comparison of Continuing Adjuvant Tamoxifen to 10 Years Compared to Stopping After 5 Years in 6953 Women with ER Positive or ER Untested Early Breast Cancer. 2013.
Παραπομπή σε μορφή MLA (9th εκδ.)Rea, D., et al. Overall and Subgroup Findings of the ATTom Trial: A Randomised Comparison of Continuing Adjuvant Tamoxifen to 10 Years Compared to Stopping After 5 Years in 6953 Women with ER Positive or ER Untested Early Breast Cancer. 2013.